XtalPi Nominates First siRNA Preclinical Candidate for IgA Nephropathy After Nine Months
XtalPi nominated its first internally developed siRNA preclinical candidate for IgA nephropathy following a nine-month discovery program. The candidate achieved subnanomolar silencing potency, with IC50 values tens of times lower than two clinical-stage reference molecules under corresponding assay conditions. A single